These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 25497318

  • 21. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246
    [Abstract] [Full Text] [Related]

  • 22. Conception, preparation and properties of functional carrier particles for pulmonary drug delivery.
    Odziomek M, Sosnowski TR, Gradoń L.
    Int J Pharm; 2012 Aug 20; 433(1-2):51-9. PubMed ID: 22580211
    [Abstract] [Full Text] [Related]

  • 23. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H, Teo J, Chew JW, Hadinoto K.
    Int J Pharm; 2016 Feb 29; 499(1-2):38-46. PubMed ID: 26757148
    [Abstract] [Full Text] [Related]

  • 24. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery.
    Rattanupatam T, Srichana T.
    Drug Deliv; 2014 Sep 29; 21(6):397-405. PubMed ID: 24401124
    [Abstract] [Full Text] [Related]

  • 25. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
    Pinto JT, Zellnitz S, Guidi T, Roblegg E, Paudel A.
    Mol Pharm; 2018 Jul 02; 15(7):2827-2839. PubMed ID: 29856921
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices.
    Ooi J, Gill C, Young PM, Traini D.
    Curr Drug Deliv; 2015 Jul 02; 12(1):40-6. PubMed ID: 25146438
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Spray-Congealing and Wet-Sieving as Alternative Processes for Engineering of Inhalation Carrier Particles: Comparison of Surface Properties, Blending and In Vitro Performance.
    Pinto JT, Zellnitz S, Guidi T, Schiaretti F, Schroettner H, Paudel A.
    Pharm Res; 2021 Jun 02; 38(6):1107-1123. PubMed ID: 34114162
    [Abstract] [Full Text] [Related]

  • 32. Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler.
    Ferdynand MS, Nokhodchi A.
    Drug Deliv Transl Res; 2020 Oct 02; 10(5):1418-1427. PubMed ID: 31933129
    [Abstract] [Full Text] [Related]

  • 33. Effects of formulation and operating variables on zanamivir dry powder inhalation characteristics and aerosolization performance.
    Yang Y, Yang Z, Ren Y, Mei X.
    Drug Deliv; 2014 Sep 02; 21(6):480-6. PubMed ID: 24491208
    [Abstract] [Full Text] [Related]

  • 34. Novel dry powder inhalation system based on dispersion of lyophilisates.
    Claus S, Schoenbrodt T, Weiler C, Friess W.
    Eur J Pharm Sci; 2011 May 18; 43(1-2):32-40. PubMed ID: 21440061
    [Abstract] [Full Text] [Related]

  • 35. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C, MacRitchie HB, Zeng XM, Martin GP.
    Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848
    [Abstract] [Full Text] [Related]

  • 36. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers.
    Young PM, Wood O, Ooi J, Traini D.
    Int J Pharm; 2011 Sep 15; 416(1):129-35. PubMed ID: 21708238
    [Abstract] [Full Text] [Related]

  • 37. The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate.
    Tee SK, Marriott C, Zeng XM, Martin GP.
    Int J Pharm; 2000 Nov 04; 208(1-2):111-23. PubMed ID: 11064216
    [Abstract] [Full Text] [Related]

  • 38. Tribo-Charging Behaviour of Inhalable Mannitol Blends with Salbutamol Sulphate.
    Zellnitz S, Pinto JT, Brunsteiner M, Schroettner H, Khinast J, Paudel A.
    Pharm Res; 2019 Apr 09; 36(6):80. PubMed ID: 30968221
    [Abstract] [Full Text] [Related]

  • 39. Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols.
    Chew NY, Chan HK.
    Pharm Res; 1999 Jul 09; 16(7):1098-103. PubMed ID: 10450937
    [Abstract] [Full Text] [Related]

  • 40. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO, Corrigan OI, Healy AM.
    Int J Pharm; 2006 Sep 28; 322(1-2):22-30. PubMed ID: 16815654
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.